Investor News View all

Doseology Announces Management Change
Doseology Launches Medicinal Mushroom Product Line in Canada to Supply Increasing Demand
Doseology Names CFO and Appoints New Board Member
Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage
Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line
Investor Year End Update
Doseology Prepares to Expand Mushroom Production by Hiring Dr. Wellman-Labadie to Oversee Planned Research and Development Laboratory
Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer’s License Application
Doseology Set to Trade CSE: MOOD